Biogen (BIIB) Accumulated Expenses (2010 - 2012)

Biogen (BIIB) has reported Accumulated Expenses for 3 consecutive years, with $48.9 million the latest figure, recorded in Q2 2012.

• In Q2 2012, Accumulated Expenses changed N/A year-over-year to $48.9 million; the TTM figure through Jun 2012 stood at $48.9 million (changed N/A YoY), while the FY2011 annual figure was $176.3 million, up 165.51% from the prior year.
• Accumulated Expenses came in at $48.9 million for Q2 2012 at Biogen, down from $108.5 million in the prior quarter.
• The five-year high for Accumulated Expenses was $176.3 million in Q4 2011, with the low at $48.9 million in Q2 2012.
• Average Accumulated Expenses over 3 years is $100.0 million, with a median of $87.4 million recorded in 2010.
• The largest YoY upside for Accumulated Expenses was 165.51% in 2011 against a maximum downside of 165.51% in 2011.
• Year by year, Accumulated Expenses stood at $66.4 million in 2010, then jumped by 165.51% to $176.3 million in 2011, then sank by 72.26% to $48.9 million in 2012.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $48.9 million, $108.5 million, and $176.3 million for Q2 2012, Q1 2012, and Q4 2011 respectively.